LYBMESCA

Pharmaceutical preparations for the treatment of cerebrovascular disease, cerebral infarction, myocardial infarction, cardiomyopathy, ischemic heart disease, epidermolysis bullosa, intractable skin ulcers, spinal cord injury, amyotrophic lateral sclerosis, traumatic brain injury, ulcerative colitis, osteoarthritis, pulmonary fibrosis and atopic dermatitis